Back
Day Range
$18.93
$19.91
52-Week Range
$1.03
$19.91
Volume
2,846,519
50D / 200D Avg
$13.42
/
$8.90
Prev Close
$19.42
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -21.7 | 0.4 |
| P/B | 6.4 | 2.9 |
| ROE % | -37.2 | 3.8 |
| Net Margin % | -162.9 | 3.9 |
| Rev Growth 5Y % | 13.9 | 10.0 |
| D/E | 0.1 | 0.2 |
Key Takeaways
Revenue grew 13.92% annually over 5 years — strong growth
Debt/Equity of 0.10 — conservative balance sheet
Negative free cash flow of -139.93M
PEG of 0.38 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 34.37%
Capital efficient — spends only 1.68% of revenue on capex
Growth
Revenue Growth (5Y)
13.92%
Revenue (1Y)48.29%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-37.23%
ROIC-21.98%
Net Margin-162.85%
Op. Margin-178.39%
Safety
Debt / Equity
0.10
Current Ratio16.32
Interest Coverage0.00
Valuation
P/E Ratio
-21.68
P/B Ratio6.36
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 48.29% | Revenue Growth (3Y) | 30.69% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 13.92% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 62.38M | Net Income (TTM) | -101.59M |
| ROE | -37.23% | ROA | -25.48% |
| Gross Margin | 96.34% | Operating Margin | -178.39% |
| Net Margin | -162.85% | Free Cash Flow (TTM) | -139.93M |
| ROIC | -21.98% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.10 | Current Ratio | 16.32 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -21.68 | P/B Ratio | 6.36 |
| P/S Ratio | 35.31 | PEG Ratio | 0.38 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 2.20B | Enterprise Value | 2.12B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 62.38M | 42.07M | 36.53M | 24.86M | 37.04M |
| Net Income | -101.59M | -130.30M | -101.74M | -108.18M | -58.24M |
| EPS (Diluted) | -0.87 | -1.19 | -1.08 | -1.23 | -0.94 |
| Gross Profit | 60.10M | 42.07M | 36.53M | 24.86M | 37.04M |
| Operating Income | -111.29M | -145.60M | -114.17M | -111.07M | -58.19M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 398.69M | 316.49M | 402.57M | 436.47M | 500.16M |
| Total Liabilities | 52.51M | 116.98M | 149.46M | 186.99M | 155.41M |
| Shareholders' Equity | 346.18M | 199.52M | 253.11M | 249.48M | 344.75M |
| Total Debt | 33.57M | 36.49M | 38.92M | 41.13M | 1.50M |
| Cash & Equivalents | 112.28M | 69.53M | 66.39M | 59.97M | 142.75M |
| Current Assets | 353.76M | 266.34M | 346.54M | 375.27M | 492.34M |
| Current Liabilities | 21.68M | 38.17M | 45.94M | 55.55M | 40.69M |